Streetbeat News

Price Targets

SGHT

Citigroup analyst Joanne Wuensch has downgraded Sight Sciences (NASDAQ:SGHT) from Buy to Neutral and lowered the price target from $15 to $9.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 11:10 am

FOXA

Wells Fargo analyst Steven Cahall has downgraded Fox (NASDAQ:FOXA) from Equal-Weight to Underweight and lowered the price target from $35 to $31.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 11:09 am

CAVA

Piper Sandler analyst Brian Mullan has initiated coverage on Cava Group (NYSE:CAVA) with an Overweight rating and a price target of $45.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 11:02 am

FFBC

Piper Sandler analyst Scott Siefers has upgraded First Financial Bancor (NASDAQ:FFBC) from Neutral to Overweight and raised the price target from $23 to $24.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 11:01 am

IAS

Piper Sandler analyst Matt Farrell has initiated coverage on Integral Ad Science (NASDAQ:IAS) with an Overweight rating and a price target of $21.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 10:59 am

KALV

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on KalVista Pharma (NASDAQ:KALV) and maintained a price target of $16.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 10:19 am

PTGX

HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Protagonist Therapeutics (NASDAQ:PTGX) and maintained a price target of $38.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 10:19 am

UEC

HC Wainwright & Co. analyst Heiko Ihle has reiterated a 'Buy' rating on Uranium Energy (AMEX:UEC) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 10:18 am

SPLK

Needham analyst Mike Cikos has reiterated a 'Buy' rating on Splunk (NASDAQ:SPLK) and maintained a price target of $125.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 10:17 am

MASI

Needham analyst Mike Matson has reiterated a 'Buy' rating on Masimo (NASDAQ:MASI) and maintained a price target of $207.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 10:16 am